April 14, 2021
Business News

The Law Offices of Frank R. Cruz Announces Investigation of Athenex, Inc. (ATNX) on Behalf of Investors


LOS ANGELES–()–The Law Offices of Frank R. Cruz announces an investigation of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

Athenex is a clinical stage biopharmaceutical company. Its main product candidate is an oral paclitaxel and encequidar for the treatment of metastatic breast cancer.

On September 1, 2020, the Company announced that the U.S. Food and Drug Administration (“FDA”) accepted Athenex’s New Drug Application (“NDA”) for oral paclitaxel and encequidar in metastatic breast cancer with priority…



Click here to view the original article.

Related Posts

You might also like ...

Riassunto: Velodyne propone le sue avanzate soluzioni lidar al salone dell’automobile Auto Shanghai 2021
L3Harris Technologies and American Rheinmetall Vehicles Team to Pursue US Army’s New Fighting Vehicle
ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Is Investigating AdaptHealth Corporation on Behalf AdaptHealth Stockholders and Encourages Investors to Contact the Firm